Predicting long-term survival, and the need for hormonal therapy: a meta-analysis of RTOG prostate cancer trials

This publication has 19 references indexed in Scilit:

• 2135 3D conformal radiotherapy improves PSA failure rates for intermediate risk patients at conventional doses
  International Journal of Radiation Oncology*Biology*Physics, 1999
• 4 Preliminary results of a randomized dose-escalation study comparing 70 GY to 78 GY for the treatment of prostate cancer
  International Journal of Radiation Oncology*Biology*Physics, 1999
• 1006 bNED control: Praying to a false god?
  International Journal of Radiation Oncology*Biology*Physics, 1997
• 1007 The need for central pathology tumor grading in prostate cancer using radiation therapy oncology group(RTOG) 8531
  International Journal of Radiation Oncology*Biology*Physics, 1997
• Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin
  New England Journal of Medicine, 1997
• Radiotherapy for High Grade Clinically Localized Adenocarcinoma of the Prostate
  Journal of Urology, 1996
• Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the radiation therapy oncology group
  Urology, 1995
• Hormonal cytoreduction in locally advanced carcinoma of the prostate treated with definitive radiotherapy: Preliminary results of RTOG 83-07
  International Journal of Radiation Oncology*Biology*Physics, 1989
• Elective pelvic irradiation in stage A2, B carcinoma of the prostate: analysis of RTOG 77-06
  International Journal of Radiation Oncology*Biology*Physics, 1988
• Prognostic factors in carcinoma of the prostate— analysis of rtog study 75-06
  International Journal of Radiation Oncology*Biology*Physics, 1987